---
title: "Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294131727.md"
description: "Morgan Stanley analyst maintained a Buy rating on CSPC Pharmaceutical Group on July 27 and set a price target of HK$11.00. The company’s shares closed last Friday at HK$8.30.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks CSPC Pharmaceutical Group has an analyst consensus of Moderate Buy, with a price target consensus of HK$11.84."
datetime: "2026-07-29T00:36:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294131727.md)
  - [en](https://longbridge.com/en/news/294131727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294131727.md)
generator: "portal-rs"
---

# Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)

Morgan Stanley analyst maintained a Buy rating on CSPC Pharmaceutical Group on July 27 and set a price target of HK$11.00. The company’s shares closed last Friday at HK$8.30.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

CSPC Pharmaceutical Group has an analyst consensus of Moderate Buy, with a price target consensus of HK$11.84.

### Related Stocks

- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [CSPC Pharma wins China NMPA clearance to start Phase 1 trial of SYH2092 obesity drug](https://longbridge.com/en/news/297512143.md)
- [CSPC’s SYS6010 Wins Third Breakthrough Therapy Tag in High-Need Cancer Indications](https://longbridge.com/en/news/297638498.md)
- [These Were The Best And Worst Performing Assets Of August](https://longbridge.com/en/news/297728245.md)
- [AcuCort notifies availability of August 2026 newsletter press release](https://longbridge.com/en/news/297505730.md)
- [eDreams ODIGEO Beats Market Estimates One Quarter Into Its Peak Investment Year and Further Grows Subscribers to 8.1 Million | EDDRF Stock News](https://longbridge.com/en/news/297623101.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**